When Using DOPPS Slides
DOPPS Slide Use Guidelines
International Trends in Erythropoietin
Use and Hemoglobin Levels in
Hemodialysis Patients
Introduction
DOPPS Background (1)
DOPPS Background (2)
Methods (1)
Methods (2)
Methods (3)
Table 1: Selected demographic parameters among
DOPPS countries (1)
Table 1: Selected demographic parameters among
DOPPS countries (2)
Table 1: Selected demographic parameters among
DOPPS countries (3)
Table 1: Selected demographic parameters among
DOPPS countries (5)
Table 2: Changes in mean Hgb levels and % of
patients with Hgb level above 12.0 g/dL (1)
Table 2: Changes in mean Hgb levels and % of
patients with Hgb level above 12.0 g/dL (2)
Figure 1: Mean ESA dose and Hgb level
Table 3: Changes in mean ESA dose (1)
Table 3: Changes in mean ESA dose (2)
Table 4: Changes in percentage of patients with
mean ESA dose greater than 35,000 U/weeka
Table 5: Changes in mean monthly intravenous iron
dose (mg/month)
Table 6: Changes in median hemoglobin levels and
median ESA dose (1)
Table 6: Changes in median hemoglobin levels and
median ESA dose (2)
Table 7: Answers from DOPPS III Questionnaire
Anemia Management Section
Figure 2: Hemoglobin target range for adult
hemodialysis patients on an ESA
Conclusions
Acknowledgements